ABT-925 ANHYDROUS FREE BASE (UNII: E6CKI5C54O) (ABT-925 ANHYDROUS FREE BASE - UNII:E6CKI5C54O) - rizultati

mabthera sc 1400

roche products (pty) ltd - rituximab - injectable; injection - 1400; 11.7mg/ml

mabthera (100mg/10ml, 500mg/50ml) concentrado para solución para infusión i.v.

f. hoffmann la roche s.a. - rituximab - rituximab....10 mg

mabthera 10mg/ml (500mg/50ml y 100mg/10ml) concentrado para solucion para infusion i.v.

f. hoffmann-la roche s.a. - rituximab - rituximab....10.00 mg

mabthera 10mg-1ml conc. for i.v infusion concentrate and diluent for solution for infusion

roche, switzerland - rituximab - concentrate and diluent for solution for infusion - 10 mg/ml

mabthera 10mg-1ml conc. for i.v infusion concentrate and diluent for solution for infusion

roche, switzerland - rituximab - concentrate and diluent for solution for infusion - 10 mg/ml

mabthera 120 mg/ml solution for subcutaneous for injection concentrate and diluent for solution for infusion

f.hoffmann-la roche ltd., switzerland - rituximab - concentrate and diluent for solution for infusion - 120 mg/ml

mabthera 119.4 mg solution for subcutaneous injection concentrate and diluent for solution for infusion

roche, switzerland - rituximab - concentrate and diluent for solution for infusion - 119.4 mg

mabthera 1400 mg / 11.7 ml solucion para inyeccion s.c.

f. hoffmann - la roche s.a. - rituximab - rituximab....1400mg

mabthera solution for injection 100

f.hoffmann-la roche limited, switzerland - rituximab - solution for injection - 100

mabthera injection 1600 mg

f.hoffmann-la roche limited, switzerland - rituximab - injection - 1600 mg